Literature DB >> 3552817

Basal and 24-h C-peptide and insulin secretion rate in normal man.

Y T Kruszynska, P D Home, I Hanning, K G Alberti.   

Abstract

An understanding of the metabolic abnormalities rising from inappropriate insulin delivery in diabetic patients demands a knowledge of 24-h and basal insulin secretion rates in normal man. We have used biosynthetic human C-peptide to determine its kinetic parameters in 10 normal subjects and applied these to measurements of plasma concentrations in the same subjects to determine pancreatic secretion rate. Metabolic clearance rate measured by stepped primed infusion of biosynthetic human C-peptide at rates of 10, 19 and 26 nmol/h was 4.7 +/- 0.7 (+/- SD) ml X kg-1 X min-1, and was independent of infusion rate. Fractional clearance (T1/2, 26 +/- 3 min) and distribution volume (0.178 +/- 0.039 l/kg) were calculated from the decline in concentration after cessation of the highest rate infusion. Basal insulin secretion calculated from the C-peptide metabolic clearance rate and plasma concentrations for the period 02.00 to 07.00 hours was 1.3 +/- 0.4 U/h. Over 24 h total insulin secretion on a standard high carbohydrate diet was 63 +/- 15 U, calculated from the area under the C-peptide concentration curve. Basal insulin secretion, therefore, accounted for 50 +/- 8% of total insulin secretion. Although only 5.6 +/- 1.1% of C-peptide was detected in 24-h urine collections, urinary C-peptide excretion was significantly related to 24-h C-peptide secretion (r = 0.74, p less than 0.02).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3552817     DOI: 10.1007/BF01788901

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  26 in total

1.  Hepatic glycogen metabolism and insulin receptor status after long-term peripheral insulin delivery in the islet-transplanted diabetic rat.

Authors:  Y T Kruszynska; P D Home; L Agius; K G Alberti
Journal:  Diabetes       Date:  1986-03       Impact factor: 9.461

2.  Use of a common standard for comparison of insulin C-peptide measurements by different laboratories.

Authors:  C P Caygill; R E Gaines Das; D R Bangham
Journal:  Diabetologia       Date:  1980-03       Impact factor: 10.122

3.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

4.  Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man.

Authors:  W Waldhäusl; P Bratusch-Marrain; S Gasic; A Korn; P Nowotny
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

5.  The limitations to and valid use of C-peptide as a marker of the secretion of insulin.

Authors:  K Polonsky; B Frank; W Pugh; A Addis; T Karrison; P Meier; H Tager; A Rubenstein
Journal:  Diabetes       Date:  1986-04       Impact factor: 9.461

6.  Metabolism of proinsulin, insulin, and C-peptide in the rat.

Authors:  A I Katz; A H Rubenstein
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

7.  Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  W Waldhäusl; P Bratusch-Marrain; S Gasić; A Korn; P Nowotny
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122

8.  Comparison of portal and peripheral insulin delivery on carbohydrate metabolism in streptozotocin-diabetic rats.

Authors:  Y T Kruszynska; P D Home; K G Alberti
Journal:  Diabetologia       Date:  1985-03       Impact factor: 10.122

9.  A comparison of the activity and disposal of semi-synthetic human insulin and porcine insulin in normal man by the glucose clamp technique.

Authors:  P D Home; M Massi-Benedetti; G A Shepherd; I Hanning; K G Alberti; D R Owens
Journal:  Diabetologia       Date:  1982-01       Impact factor: 10.122

10.  Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

Authors:  R P Eaton; R C Allen; D S Schade; K M Erickson; J Standefer
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

View more
  26 in total

1.  Disorders of glucose metabolism: post mortem analyses in forensic cases--part II.

Authors:  Frank Musshoff; Cornelius Hess; Burkhard Madea
Journal:  Int J Legal Med       Date:  2010-10-07       Impact factor: 2.686

2.  Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM.

Authors:  K Ratheiser; W Reitgruber; M Komjati; P Bratusch-Marrain; H Vierhapper; W K Waldhäusl
Journal:  Acta Diabetol Lat       Date:  1990 Jul-Sep

Review 3.  The Need for Faster Insulin.

Authors:  Douglas B Muchmore
Journal:  J Diabetes Sci Technol       Date:  2016-11-10

4.  Urinary C-peptide excretion: a novel alternate measure of insulin sensitivity in physiological conditions.

Authors:  Jose E Galgani; Lilian de Jonge; Jennifer C Rood; Steven R Smith; Andrew A Young; Eric Ravussin
Journal:  Obesity (Silver Spring)       Date:  2010-04-01       Impact factor: 5.002

Review 5.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

6.  Galactose promotes fat mobilization in obese lactating and nonlactating women.

Authors:  Mahmoud A Mohammad; Agneta L Sunehag; Luisa A Rodriguez; Morey W Haymond
Journal:  Am J Clin Nutr       Date:  2010-12-01       Impact factor: 7.045

Review 7.  Reassessment of insulin dosing guidelines in continuous subcutaneous insulin infusion treated type 1 diabetes.

Authors:  Allen Bennett King
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

8.  Chitosan-zinc-insulin complex incorporated thermosensitive polymer for controlled delivery of basal insulin in vivo.

Authors:  Mayura Oak; Jagdish Singh
Journal:  J Control Release       Date:  2012-08-07       Impact factor: 9.776

9.  Relationship between whole-body macronutrient oxidative partitioning and pancreatic insulin secretion/β-cell function in non-diabetic humans.

Authors:  Jose E Galgani; Maria L Mizgier; Andrea Mari; Eric Ravussin
Journal:  Metabolism       Date:  2014-08-07       Impact factor: 8.694

10.  Cost-effectiveness of long-acting insulin analogues vs intermediate/long-acting human insulin for type 1 diabetes: A population-based cohort followed over 10 years.

Authors:  Tsung-Ying Lee; Shihchen Kuo; Chen-Yi Yang; Huang-Tz Ou
Journal:  Br J Clin Pharmacol       Date:  2020-01-23       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.